DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
AUGX logo

Augmedix, Inc. Stock Price

NasdaqCM:AUGX Community·US$116.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

AUGX Share Price Performance

US$0
0.00 (0.00%)
​
US$0
0.00 (0.00%)
​
Price US$0
Thu, 10 Sep 26
Share Pricen/a

AUGX Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet slight.

4 Risks
1 Reward
View Full Analysis

Augmedix, Inc. Key Details

US$51.6m

Revenue

US$26.7m

Cost of Revenue

US$24.9m

Gross Profit

US$48.7m

Other Expenses

-US$23.8m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.48
48.22%
-46.23%
196.1%
View Full Analysis

About AUGX

Founded
2013
Employees
1430
CEO
Emmanuel Krakaris
WebsiteView website
www.augmedix.com

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California.

Recent AUGX News & Updates

Recent updates

No updates

Augmedix, Inc. Competitors

VMD logo

Viemed Healthcare

Symbol: NasdaqCM:VMD
Market cap: US$334.8m
OBIO logo

Orchestra BioMed Holdings

Symbol: NasdaqGM:OBIO
Market cap: US$326.4m
SMTI logo

Sanara MedTech

Symbol: NasdaqCM:SMTI
Market cap: US$321.9m
CV logo

CapsoVision

Symbol: NasdaqCM:CV
Market cap: US$318.8m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide